P’ng Loke, Ph.D.

P’ng Loke, Ph.D.

Credit: NIAID
Chief, Type 2 Immunity Section

Major Areas of Research

  • Type 2 cytokine (IL-4 and IL-13) activated macrophages during helminth infections
  • Role of microbiota during helminth infections
  • Genetic and environmental contributions towards immune variation between individuals
  • Helminth infections, inflammatory bowel diseases, metabolic syndrome, atherosclerosis, chronic inflammation

Biography

Dr. P’ng Loke completed his Ph.D. research at the University of Edinburgh on IL-4 activated macrophages responding to Brugia malayi filarial parasites in 2001. He then did postdoctoral research on costimulatory molecules at University of California-Berkeley and studied macrophage responses to different parasites at University of California-San Francisco. In 2009, he joined New York University School of Medicine as an assistant professor and was a tenured associate professor before he joined the Laboratory of Parasitic Diseases as a senior investigator in 2020.

Program Description

Our research goal is to understand the heterogeneity of type-2 immune responses during helminth infections. Although we have co-evolved with helminths and most infections are asymptomatic, these parasites can cause pathology in some individuals that either mount a response that is too strong or too weak during infection. An appropriately regulated type-2 response is critical in maintaining the balance between expelling enough parasites and tolerating the remaining parasites without excessive collateral tissue damage, in order to maintain the fitness of the host.

Type-2 immunity induced by helminth infections may be therapeutically beneficial for improving symptoms of inflammatory bowel diseases and metabolic syndrome, but this may also benefit only specific subsets of individuals. The mechanisms underlying the heterogeneity of type-2 responses between individuals still remains poorly understood. We believe that characterizing these mechanisms will enable us to develop strategies to utilize helminth infections as treatment for specific inflammatory conditions (e.g., autoimmune diseases and metabolic conditions) for the right individuals, as well as designing better approaches toward limiting pathology that is caused by helminth infections.

Our basic immunological studies on macrophage biology and our translational research studies on the microbiota are converging toward the goal of understanding factors that regulate variation of type-2 immune responses in humans. Using a combination of mouse models, as well as field and clinical studies, our future plans are to test some of the concepts that we have developed on chromatin remodeling in macrophage responses to type-2 cytokines, as well as helminth-microbiota interactions, in mouse models, field studies and also human challenge infections.

Research Group

Jian-Da Lin, Ph.D., Staff Scientist

Selected Publications

Lee SC, Tang MS, Easton AV, Devlin JC, Chua LL, Cho I, Moy FM, Khang TF, Lim YAL, Loke P. Linking the effects of helminth infection, diet and the gut microbiota with human whole-blood signatures. PLoS Pathog. 2019 Dec 16;15(12):e1008066.

Gundra UM, Girgis NM, Gonzalez M, Ouimet M, Tang MS, Vozhilla N, Fisher EA, Moore KJ, Loke P. Vitamin A mediates conversion of monocyte-derived macrophages into tissue-resident macrophages during alternative activation. Nature Immunology. 2017 Jun;18(6):642-653.

Ramanan D*, Bowcutt R*, Lee SC, Tang MS, Honda K, Gause WC, Lim YAL, Loke P**, Cadwell K**. Helminth infection promotes colonization resistance via type 2 immunity. Science. 2016 Apr 29;352(6285):608-12. * Equally contributing first authors. ** Equally contributing senior authors.

Gundra UM, Girgis NM, Ruckerl D, Jenkins S, Ward LN, Kurtz ZD, Wiens KE, Tang MS, Basu-Roy U, Mansukhani A, Allen JE, Loke P. Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood. 2014 May 15;123(20):e110-22.

Broadhurst MJ, Leung JM, Kashyap V, McCune JM, Mahadevan U, McKerrow JH, Loke P. IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patient. Sci Transl Med. 2010 Dec 1;2(60):60ra88.

Visit PubMed for a complete publication list.

Content last reviewed on